Integration of Parry Labs' mission computing and MOSA architecture strengthens AV's P550 capabilities for the Army's Long Range Reconnaissance mission ALEXANDRIA, Va., Jan. 9, 2026 /PRNewswire/ -- Parry Labs , a defense technology company delivering modular open systems and edge infrastructure for the modern battlespace, is partnering with AeroVironment Inc ("AV") (NASDAQ: AVAV) to architect, develop, deliver, and integrate Modular Open Systems Approach (MOSA)-aligned digital engineering, software, and mission system hardware for the newly developed P550™ uncrewed aircraft system (UAS) for the U.S. Army's Long Range Reconnaissance (LRR) program.

Marsh McLennan (MMC) stands out as a top-tier compounder, combining scale, brand power, and consistent financial growth. MMC has delivered robust revenue and net income CAGR—9% and 15.4% respectively—while actively reducing the outstanding share count. The stock trades at a historical discount (3.5x sales, 22.4x earnings), offering an attractive entry point amid cyclical insurance rate headwinds.

MKTX sees 4Q25 ADV slip 8% to $37.9B as rates volumes fall, but Eurobonds and EM credit growth lift total credit trading.

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sprouts Farmers Market, Inc. (“Sprouts” or “the Company”) (NASDAQ: SFM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 4, 2025 and October 29, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 26, 2026.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bitdeer To Contact Him Directly To Discuss Their Options

Shipping subsidies are driving MELI's GMV surge, but rising logistics costs and squeezed margins raise questions about how durable that growth can be.

Jabil (JBL) is being driven by accelerating AI-related revenue growth and strategic expansion in AI infrastructure. AI-related revenue surged 80% YoY in FY2025 and is guided to grow 34.4% in FY2026, expected to reach 36% of total revenue. JBL's scale, supplier depth, and $500M AI-focused capex position it to capitalize on hyperscale AI demand despite ongoing weakness in legacy segments.

Most U.S. investors never look beyond domestic stocks for dividend income, and the reasoning, at least on the surface, seems logical.

Airbus (EADSY) maintains operational stability, higher margins, and a robust commercial aircraft portfolio, as Boeing (BA) addresses deficiencies in 2026. Airbus and Boeing benefit from a strong duopoly and extensive order backlogs amid strong global travel demand. Supply chain constraints and engine reliability issues remain the primary bottlenecks for production increases at both airframe manufacturers.

Resources Connection, Inc. maintains a Hold rating amid revenue pressure, aggressive cost-cutting, and a strong cash position with zero debt. Q2 results disappointed on profitability, with a $12.7 million GAAP loss driven by CEO transition and headcount reduction costs, despite revenues meeting guidance. Shares trade near intrinsic value, under two times cash and below book value, with a calculated no-growth valuation of $4.46 per share.

Shares of Apple (NASDAQ:AAPL) plunged into correction territory on Thursday as the losing streak extended to a whopping seven sessions.

Visa (V) stock could be an appealing purchase at this time. Why? Because it offers high margins – indicative of pricing strength and cash generation capabilities – at a discounted price.

Alphabet (GOOGL) stock has meaningfully outpaced its mega-cap peers over the last year, but how does it really stack up against giants accelerating in AI and cloud? Currently, the numbers point to strong profitability, with an operating margin of 32% and an FCF margin of 19%, supported by a good 13% LTM revenue growth.

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria” or “the Company”) (NYSE: ARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 27, 2025 and October 27, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 26, 2026.

CARY, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced preliminary, unaudited fourth quarter and full-year 2025 net revenue. “We are encouraged by the growth in Q4 2025, driven in particular by the momentum in our Acute Care franchise with ZYNRELEF® and APONVIE®,” said Craig Collard, Chief Executive Officer of Heron.

BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced that it will release operating results for the first quarter of fiscal 2026 on Tuesday, February 3, 2026, after the market close. The Company will host a conference call and live webcast to review the first quarter results beginning at 8:00 am (ET) on Wednesday, February 4, 2026.

For all of its many achievements in 2025, D-Wave Quantum Inc. NYSE: QBTS remains a speculative and controversial investment. The much-hyped quantum computing firm more than tripled in value in the last year with returns of more than 232%, but it has a fairly high short interest of 12.47% of the public float, meaning that a sizable number of investors are skeptical that the firm will be able to maintain its trajectory.

United Community Banks, Inc. (NYSE: UCB) will release earnings results for the fourth quarter, before the opening bell on Wednesday, Jan. 14, 2025.

HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has entered into a non-binding memorandum (the “Investment Memorandum”) with Future Biotechnology Group Co., Ltd (hereinafter referred to as “Future Biotechnology Group”). The Investment Memorandum outlines an initial investment of US$30 million to be paid in cash, as well as subsequent acquisitions with a consideration, in aggregate, of US$60 million to be settled in cash and share issuances (the “Consideration Shares”).

The toy company is still at risk from Donald Trump's tariffs.